ATLAS CAPITAL ADVISORS LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
ATLAS CAPITAL ADVISORS LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$297,106
+22.4%
10,9050.0%0.05%
+32.4%
Q2 2023$242,636
+2.7%
10,9050.0%0.04%0.0%
Q1 2023$236,202
+6.6%
10,9050.0%0.04%0.0%
Q4 2022$221,480
-99.9%
10,9050.0%0.04%
-27.5%
Q3 2022$279,604,000
+7.8%
10,9050.0%0.05%
+15.9%
Q2 2022$259,320,000
+5.6%
10,9050.0%0.04%
+15.8%
Q1 2022$245,581,000
+13.7%
10,9050.0%0.04%
+18.8%
Q4 2021$215,919,000
+0.6%
10,9050.0%0.03%
-5.9%
Q3 2021$214,610,000
-10.5%
10,9050.0%0.03%
-15.0%
Q2 2021$239,910,000
-7.5%
10,9050.0%0.04%
-20.0%
Q1 2021$259,429,000
-9.1%
10,9050.0%0.05%
-16.7%
Q4 2020$285,274,000
+50.3%
10,9050.0%0.06%
+33.3%
Q3 2020$189,801,000
+3.5%
10,9050.0%0.04%
+4.7%
Q2 2020$183,422,000
+41.5%
10,9050.0%0.04%
+10.3%
Q1 2020$129,660,000
-1.7%
10,9050.0%0.04%
+18.2%
Q4 2019$131,950,000
-14.4%
10,9050.0%0.03%
-28.3%
Q3 2019$154,142,000
+26.8%
10,9050.0%0.05%
+15.0%
Q2 2019$121,590,000
-5.0%
10,9050.0%0.04%
-13.0%
Q1 2019$128,024,000
-12.1%
10,9050.0%0.05%
-20.7%
Q4 2018$145,690,000
-7.9%
10,9050.0%0.06%
+9.4%
Q3 2018$158,232,000
+4.4%
10,9050.0%0.05%
-1.9%
Q2 2018$151,580,000
-7.9%
10,905
+9.0%
0.05%
+8.0%
Q1 2018$164,500,00010,0000.05%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders